Compare, Analyse SUVEN LIFE with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFESCIENCES vs MYLAN (US) - Comparison Results

MYLAN (US)
   Change

Mylan is one of the worlds leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industrys broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 SUVEN LIFESCIENCES   MYLAN
EQUITY SHARE DATA
    SUVEN LIFESCIENCES
Mar-19
MYLAN
Dec-18
SUVEN LIFESCIENCES/
MYLAN
5-Yr Chart
Click to enlarge
High Rs3383,510-   
Low Rs1691,932-   
Sales per share (Unadj.) Rs52.11,615.1-  
Earnings per share (Unadj.) Rs6.843.9-  
Cash flow per share (Unadj.) Rs8.6346.3-  
Dividends per share (Unadj.) Rs1.500-  
Dividend yield (eoy) %0.60-  
Book value per share (Unadj.) Rs65.31,747.3-  
Shares outstanding (eoy) m127.28514.50-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.91.7 288.7%   
Avg P/E ratio x37.162.0 59.8%  
P/CF ratio (eoy) x29.67.9 376.5%  
Price / Book Value ratio x3.91.6 249.4%  
Dividend payout %22.00-   
Avg Mkt Cap Rs m32,2721,399,958 2.3%   
No. of employees `0001.135.0 3.1%   
Total wages/salary Rs m6610-   
Avg. sales/employee Rs Th6,132.223,742.2 25.8%   
Avg. wages/employee Rs Th611.10-   
Avg. net profit/employee Rs Th803.5644.7 124.6%   
INCOME DATA
Net Sales Rs m6,635830,976 0.8%  
Other income Rs m2420-   
Total revenues Rs m6,877830,976 0.8%   
Gross profit Rs m1,604215,026 0.7%  
Depreciation Rs m221155,591 0.1%   
Interest Rs m3839,967 0.1%   
Profit before tax Rs m1,58719,467 8.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m718-3,097 -23.2%   
Profit after tax Rs m86922,564 3.9%  
Gross profit margin %24.225.9 93.4%  
Effective tax rate %45.2-15.9 -284.3%   
Net profit margin %13.12.7 482.6%  
BALANCE SHEET DATA
Current assets Rs m6,232464,016 1.3%   
Current liabilities Rs m1,490338,319 0.4%   
Net working cap to sales %71.515.1 472.5%  
Current ratio x4.21.4 304.9%  
Inventory Days Days8684 103.4%  
Debtors Days Days8393 88.5%  
Net fixed assets Rs m4,043161,196 2.5%   
Share capital Rs m127442 28.8%   
"Free" reserves Rs m8,1830-   
Net worth Rs m8,310898,964 0.9%   
Long term debt Rs m18970,271 0.0%   
Total assets Rs m10,3892,411,372 0.4%  
Interest coverage x43.11.5 2,898.7%   
Debt to equity ratio x01.1 0.2%  
Sales to assets ratio x0.60.3 185.3%   
Return on assets %8.72.6 336.7%  
Return on equity %10.52.5 416.8%  
Return on capital %19.53.2 613.7%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m3,8220-   
CASH FLOW
From Operations Rs m356172,677 0.2%  
From Investments Rs m-279-89,255 0.3%  
From Financial Activity Rs m-225-80,443 0.3%  
Net Cashflow Rs m-1481,431 -10.4%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 73.74 Rs / USD

Compare SUVEN LIFESCIENCES With: ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare SUVEN LIFESCIENCES With: ORCHID PHARMA  IPCA LABS  ELDER PHARMA  PIRAMAL ENTERPRISES  SHASUN PHARMA  



Today's Market

Sensex Ends Flat; Maruti Suzuki Rallies 7.5%(Closing)

After opening the day at record high levels, Indian share markets erased gains as the session progressed and ended on a flat note, led by a decline in IT stocks and index heavyweight HDFC Bank.

Related Views On News

SUVEN LIFESCIENCES Announces Quarterly Results (1QFY20); Net Profit Up 47.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 572 m (up 47.2% YoY). Sales on the other hand came in at Rs 2 bn (up 3.8% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

SUVEN LIFESCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 22, 2019 | Updated on Jul 22, 2019

Here's an analysis of the annual report of SUVEN LIFESCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFESCIENCES. Also includes updates on the valuation of SUVEN LIFESCIENCES.

SUVEN LIFESCIENCES Announces Quarterly Results (4QFY19); Net Profit Up 8.7% (Quarterly Result Update)

May 27, 2019 | Updated on May 27, 2019

For the quarter ended March 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 680 m (up 8.7% YoY). Sales on the other hand came in at Rs 3 bn (up 18.5% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

More Views on News

Most Popular

Not Infosys or Wipro. India's Next Wealth Creators Could Be Drone Stocks (Profit Hunter)

Nov 25, 2020

India's drones directorate signals the next big defence tech multibaggers.

It's Time to Book Profits (Fast Profits Daily)

Nov 27, 2020

In my first video on Equitymaster, I want to introduce you my proprietary greed and fear index. It's telling us to book some profits in the market.

How the New Margins Will Impact You (Fast Profits Daily)

Nov 25, 2020

The new rules on margins will come into effect from 1st December. Are you ready?

Create Wealth for Yourself in India's Drone Revolution (Profit Hunter)

Nov 27, 2020

The Chinese drone market is 14 times that of India's. Billions may flow into Indian drone companies too. Don't miss out on this wealth creating opportunity.

The Price of Dying, the Cost of Living (The Honest Truth)

Nov 20, 2020

Ajit Dayal presents a cost benefit analysis of the various types of response to covid around the world.

More
-->

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2021
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

SUVEN LIFESCIENCES SHARE PRICE


Dec 3, 2020 (Close)

TRACK SUVEN LIFESCIENCES

  • Track your investment in SUVEN LIFESCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUVEN LIFESCIENCES

SUVEN LIFESCIENCES 8-QTR ANALYSIS

COMPARE SUVEN LIFESCIENCES WITH

FEATURED VIDEOS

Adani Green: A Future Multibagger or a Big, Speculative Bubble

Is M&M the ITC of Auto Sector?

Don't Let Brokerages Fool You into Buying HUL & Nestle. The Real Money is in These Stocks Right Now...

What to Expect from Stocks during Covid Second Wave?

More Featured Videos

MARKET STATS